But I did go to the Robins Kaplan website, the firm that Mark Thompson said that they were working with out of Minnesota. And again, just looking at some of the data, A 555% increased risk of developing meningioma [is associated with Depo Provera]. And this is the brain tumors, benign in most cases, but the brain tumors and the spinal cord impact as well. (1:47:34–1:47:44)
CLAIM
Asserts that there is a 555% increased risk of developing meningioma associated with Depo Provera.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
